In the last 12 months, insiders at Dyne Therapeutics, Inc. ($DYN) filed 501 transactions with the SEC: 14 open-market purchases totaling $32,086,244 and 327 sales totaling $261,648,028. Net insider sentiment: net selling.
Dyne Therapeutics, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Kersten Dirk (Not found) — 84 transactions totaling $151,284,575
- Rhodes Jason P (Not found) — 38 transactions totaling $59,258,205
- Atlas Venture Fund XI, L.P. (Not found) — 29 transactions totaling $42,833,976
- Brumm Joshua T (CEO & President) — 36 transactions totaling $23,312,814
- Scalzo Richard William (SVP, Head of Finance & Admin.) — 54 transactions totaling $9,900,811
View all SEC Filings for Dyne Therapeutics, Inc. (DYN).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | Lucera Erick | Chief Financial Officer | S | Common Stock | 5727 | $18.64 | 125,373.0000 | 142,824,687 | 4.37% | 0.00% |
| March 30, 2026 | Posner Brian S | Not found | P | Common Stock | 2000 | $17.08 | 15,500.0000 | 142,824,687 | 14.81% | 0.00% |
| March 11, 2026 | Kersten Dirk | Not found | S | Common Stock | 129672 | $19.52 | 4,644,386.0000 | 142,824,687 | 2.72% | 0.09% |
| March 11, 2026 | Posner Brian S | Not found | P | Common Stock | 2000 | $19.35 | 13,500.0000 | 142,824,687 | 17.39% | 0.00% |
| March 9, 2026 | Kersten Dirk | Not found | S | Common Stock | 177690 | $17.72 | 5,285,156.0000 | 142,824,687 | 3.25% | 0.12% |
| March 10, 2026 | Kersten Dirk | Not found | S | Common Stock | 281858 | $19.80 | 4,774,058.0000 | 142,824,687 | 5.57% | 0.20% |
| March 10, 2026 | Kersten Dirk | Not found | S | Common Stock | 9482 | $18.21 | 5,275,674.0000 | 142,824,687 | 0.18% | 0.01% |
| March 10, 2026 | Kersten Dirk | Not found | S | Common Stock | 219758 | $19.33 | 5,055,916.0000 | 142,824,687 | 4.17% | 0.15% |
| March 6, 2026 | Posner Brian S | Not found | P | Common Stock | 3000 | $15.06 | 11,500.0000 | 142,824,687 | 35.29% | 0.00% |
| March 5, 2026 | Kerr Douglas | Chief Medical Officer | S | Common Stock | 904 | $14.90 | 171,606.0000 | 142,824,687 | 0.52% | 0.00% |
| March 5, 2026 | Cox John | CEO & President | S | Common Stock | 2732 | $14.90 | 446,145.0000 | 142,824,687 | 0.61% | 0.00% |
| March 5, 2026 | Friedl-Naderer Johanna | Chief Commercial Officer | S | Common Stock | 148 | $14.90 | 154,581.0000 | 142,824,687 | 0.10% | 0.00% |
| Feb. 12, 2026 | Kerr Douglas | Chief Medical Officer | A | Stock option (right to buy) | 130000 | $0.00 | 130,000.0000 | 142,824,687 | 9999.99% | 0.09% |
| Feb. 12, 2026 | Kerr Douglas | Chief Medical Officer | A | Common Stock | 85000 | $0.00 | 172,510.0000 | 142,824,687 | 97.13% | 0.06% |
| Feb. 12, 2026 | Lucera Erick | Chief Financial Officer | A | Stock Option (Right to Buy) | 105000 | $0.00 | 105,000.0000 | 142,824,687 | 9999.99% | 0.07% |
| Feb. 12, 2026 | Lucera Erick | Chief Financial Officer | A | Common Stock | 65000 | $0.00 | 131,100.0000 | 142,824,687 | 98.34% | 0.05% |
| Feb. 12, 2026 | Friedl-Naderer Johanna | Chief Commercial Officer | A | Stock option (right to buy) | 90000 | $0.00 | 90,000.0000 | 142,824,687 | 9999.99% | 0.06% |
| Feb. 12, 2026 | Friedl-Naderer Johanna | Chief Commercial Officer | A | Common Stock | 60000 | $0.00 | 154,729.0000 | 142,824,687 | 63.34% | 0.04% |
| Feb. 12, 2026 | Cox John | CEO & President | A | Common Stock | 180000 | $0.00 | 448,877.0000 | 142,824,687 | 66.95% | 0.13% |
| Feb. 12, 2026 | Cox John | CEO & President | A | Stock option (right to buy) | 285000 | $0.00 | 285,000.0000 | 142,824,687 | 9999.99% | 0.20% |
| Dec. 22, 2025 | Karnani Vikram | Not found | A | Stock option (right to buy) | 59665 | $0.00 | 59,665.0000 | 142,824,687 | 9999.99% | 0.04% |
| Dec. 5, 2025 | Friedl-Naderer Johanna | Chief Commercial Officer | S | Common Stock | 144 | $20.72 | 94,729.0000 | 142,824,687 | 0.15% | 0.00% |
| Dec. 5, 2025 | Kerr Douglas | Chief Medical Officer | S | Common Stock | 880 | $20.72 | 87,510.0000 | 142,824,687 | 1.00% | 0.00% |
| Dec. 5, 2025 | Cox John | CEO & President | S | Common Stock | 2662 | $20.72 | 268,877.0000 | 142,824,687 | 0.98% | 0.00% |
| Oct. 1, 2025 | Posner Brian S | Not found | A | Stock option (right to buy) | 70000 | $0.00 | 70,000.0000 | 113,121,357 | 9999.99% | 0.06% |
| Sept. 5, 2025 | Cox John | CEO & President | S | Common Stock | 2640 | $13.41 | 271,539.0000 | 113,121,357 | 0.96% | 0.00% |
| Sept. 5, 2025 | Friedl-Naderer Johanna | Chief Commercial Officer | S | Common Stock | 144 | $13.41 | 94,873.0000 | 113,121,357 | 0.15% | 0.00% |
| Sept. 4, 2025 | Kerr Douglas | Chief Medical Officer | S | Common Stock | 3552 | $13.27 | 89,263.0000 | 113,121,357 | 3.83% | 0.00% |
| Sept. 5, 2025 | Kerr Douglas | Chief Medical Officer | S | Common Stock | 873 | $13.41 | 88,390.0000 | 113,121,357 | 0.98% | 0.00% |
| Sept. 4, 2025 | Friedl-Naderer Johanna | Chief Commercial Officer | S | Common Stock | 894 | $13.27 | 95,017.0000 | 113,121,357 | 0.93% | 0.00% |
| July 16, 2025 | Kerr Douglas | Chief Medical Officer | A | Stock option (right to buy) | 65110 | $0.00 | 65,110.0000 | 113,121,357 | 9999.99% | 0.06% |
| July 16, 2025 | Friedl-Naderer Johanna | Chief Commercial Officer | A | Stock option (right to buy) | 51255 | $0.00 | 51,255.0000 | 113,121,357 | 9999.99% | 0.05% |
| July 16, 2025 | Cox John | CEO & President | A | Stock option (right to buy) | 197285 | $0.00 | 197,285.0000 | 113,121,357 | 9999.99% | 0.17% |
| July 14, 2025 | Cox John | CEO & President | P | Common Stock | 100000 | $9.11 | 314,179.0000 | 113,121,357 | 46.69% | 0.09% |
| July 15, 2025 | Cox John | CEO & President | G | Common Stock | 10000 | $0.00 | 294,179.0000 | 113,121,357 | 3.29% | 0.01% |
| July 15, 2025 | Cox John | CEO & President | G | Common Stock | 10000 | $0.00 | 284,179.0000 | 113,121,357 | 3.40% | 0.01% |
| July 15, 2025 | Cox John | CEO & President | G | Common Stock | 10000 | $0.00 | 274,179.0000 | 113,121,357 | 3.52% | 0.01% |
| July 15, 2025 | Cox John | CEO & President | G | Common Stock | 10000 | $0.00 | 304,179.0000 | 113,121,357 | 3.18% | 0.01% |
| June 5, 2025 | Cox John | CEO & President | S | Common Stock | 4060 | $13.35 | 174,179.0000 | 113,121,357 | 2.28% | 0.00% |
| June 5, 2025 | Kerr Douglas | Chief Medical Officer | S | Common Stock | 1342 | $13.35 | 92,815.0000 | 113,121,357 | 1.43% | 0.00% |
| June 5, 2025 | Friedl-Naderer Johanna | Chief Commercial Officer | S | Common Stock | 146 | $13.35 | 95,911.0000 | 113,121,357 | 0.15% | 0.00% |
| May 30, 2025 | Kersten Dirk | Not found | A | Stock option (right to buy) | 35000 | $0.00 | 35,000.0000 | 113,121,357 | 9999.99% | 0.03% |
| May 30, 2025 | Stehman-Breen Catherine | Not found | A | Stock option (right to buy) | 35000 | $0.00 | 35,000.0000 | 113,121,357 | 9999.99% | 0.03% |
| May 30, 2025 | Incerti Carlo | Not found | A | Stock option (right to buy) | 35000 | $0.00 | 35,000.0000 | 113,121,357 | 9999.99% | 0.03% |
| May 30, 2025 | Rhodes Jason P | Not found | A | Stock option (right to buy) | 35000 | $0.00 | 35,000.0000 | 113,121,357 | 9999.99% | 0.03% |
| May 30, 2025 | Lubner David Charles | Not found | A | Stock option (right to buy) | 35000 | $0.00 | 35,000.0000 | 113,121,357 | 9999.99% | 0.03% |
| May 30, 2025 | HURWITZ EDWARD | Not found | A | Stock option (right to buy) | 35000 | $0.00 | 35,000.0000 | 113,121,357 | 9999.99% | 0.03% |
| March 31, 2025 | Lucera Erick | Chief Financial Officer | A | Stock Option (Right to Buy) | 214500 | $0.00 | 214,500.0000 | 113,121,357 | 9999.99% | 0.19% |
| March 31, 2025 | Lucera Erick | Chief Financial Officer | A | Common Stock | 66100 | $0.00 | 66,100.0000 | 113,121,357 | 9999.99% | 0.06% |
| March 11, 2025 | Scalzo Richard William | SVP, Head of Finance & Admin. | S | Common Stock | 1343 | $11.38 | 122,330.0000 | 113,121,357 | 1.09% | 0.00% |
| March 13, 2025 | Friedl-Naderer Johanna | Chief Commercial Officer | S | Common Stock | 143 | $12.12 | 96,057.0000 | 113,121,357 | 0.15% | 0.00% |
| March 11, 2025 | Beskrovnaya Oxana | Chief Scientific Officer | S | Common Stock | 2153 | $11.38 | 195,840.0000 | 113,121,357 | 1.09% | 0.00% |
| March 5, 2025 | Kerr Douglas | Chief Medical Officer | S | Common Stock | 1343 | $11.83 | 94,157.0000 | 113,121,357 | 1.41% | 0.00% |
| March 5, 2025 | Beskrovnaya Oxana | Chief Scientific Officer | S | Common Stock | 1094 | $11.83 | 197,993.0000 | 113,121,357 | 0.55% | 0.00% |
| March 5, 2025 | Scalzo Richard William | SVP, Head of Finance & Admin. | S | Common Stock | 917 | $11.83 | 123,673.0000 | 113,121,357 | 0.74% | 0.00% |
| March 5, 2025 | Cox John | CEO & President | S | Common Stock | 4061 | $11.83 | 178,239.0000 | 113,121,357 | 2.23% | 0.00% |
| Feb. 18, 2025 | Beskrovnaya Oxana | Chief Scientific Officer | S | Common Stock | 2598 | $13.95 | 199,087.0000 | 0 | 1.29% | 0.00% |
| Feb. 18, 2025 | Scalzo Richard William | SVP, Head of Finance & Admin. | S | Common Stock | 2488 | $13.95 | 124,590.0000 | 0 | 1.96% | 0.00% |
| Jan. 27, 2025 | Rhodes Jason P | Not found | A | Common Stock | 1111111 | $13.50 | 9,130,465.0000 | 0 | 13.86% | 0.00% |
| Dec. 11, 2024 | Beskrovnaya Oxana | Chief Scientific Officer | S | Common Stock | 2334 | $28.12 | 201,685.0000 | 0 | 1.14% | 0.00% |
| Dec. 11, 2024 | Scalzo Richard William | SVP, Head of Finance & Admin. | S | Common Stock | 1455 | $28.12 | 127,078.0000 | 0 | 1.13% | 0.00% |
| Dec. 9, 2024 | Kersten Dirk | Not found | S | Common Stock | 34437 | $29.18 | 5,462,846.0000 | 0 | 0.63% | 0.00% |
| Dec. 6, 2024 | Kersten Dirk | Not found | S | Common Stock | 101675 | $29.34 | 5,497,283.0000 | 0 | 1.82% | 0.00% |
| Dec. 4, 2024 | Kerr Douglas | Chief Medical Officer | A | Common Stock | 48000 | $0.00 | 95,500.0000 | 0 | 101.05% | 0.00% |
| Dec. 4, 2024 | Friedl-Naderer Johanna | Chief Commercial Officer | A | Common Stock | 37800 | $0.00 | 96,200.0000 | 0 | 64.73% | 0.00% |
| Dec. 4, 2024 | Friedl-Naderer Johanna | Chief Commercial Officer | A | Stock option (right to buy) | 60300 | $0.00 | 60,300.0000 | 0 | 9999.99% | 0.00% |
| Dec. 4, 2024 | Kersten Dirk | Not found | S | Common Stock | 135039 | $29.39 | 5,602,764.0000 | 0 | 2.35% | 0.00% |
| Dec. 5, 2024 | Kersten Dirk | Not found | S | Common Stock | 3806 | $29.05 | 5,598,958.0000 | 0 | 0.07% | 0.00% |
| Dec. 4, 2024 | Scalzo Richard William | SVP, Head of Finance & Admin. | A | Common Stock | 32700 | $0.00 | 128,533.0000 | 0 | 34.12% | 0.00% |
| Dec. 4, 2024 | Scalzo Richard William | SVP, Head of Finance & Admin. | A | Stock option (right to buy) | 52300 | $0.00 | 52,300.0000 | 0 | 9999.99% | 0.00% |
| Dec. 4, 2024 | Kerr Douglas | Chief Medical Officer | A | Stock option (right to buy) | 76600 | $0.00 | 76,600.0000 | 0 | 9999.99% | 0.00% |
| Dec. 4, 2024 | Cox John | CEO & President | A | Common Stock | 145300 | $0.00 | 182,300.0000 | 0 | 392.70% | 0.00% |
| Dec. 4, 2024 | Cox John | CEO & President | A | Stock option (right to buy) | 232100 | $0.00 | 232,100.0000 | 0 | 9999.99% | 0.00% |
| Dec. 4, 2024 | Beskrovnaya Oxana | Chief Scientific Officer | A | Common Stock | 39100 | $0.00 | 176,619.0000 | 0 | 28.43% | 0.00% |
| Dec. 4, 2024 | Beskrovnaya Oxana | Chief Scientific Officer | A | Common Stock | 27400 | $0.00 | 204,019.0000 | 0 | 15.51% | 0.00% |
| Dec. 4, 2024 | Beskrovnaya Oxana | Chief Scientific Officer | A | Stock option (right to buy) | 62400 | $0.00 | 62,400.0000 | 0 | 9999.99% | 0.00% |
| Dec. 3, 2024 | Kersten Dirk | Not found | S | Common Stock | 29732 | $29.05 | 5,737,803.0000 | 0 | 0.52% | 0.00% |
| Dec. 2, 2024 | Kersten Dirk | Not found | S | Common Stock | 1228 | $30.37 | 5,767,535.0000 | 0 | 0.02% | 0.00% |
| Dec. 2, 2024 | Kersten Dirk | Not found | S | Common Stock | 79973 | $29.66 | 5,768,763.0000 | 0 | 1.37% | 0.00% |
| Nov. 18, 2024 | Incerti Carlo | Not found | M | Common Stock | 16500 | $8.69 | 16,500.0000 | 0 | 9999.99% | 0.00% |
| Nov. 14, 2024 | Rhodes Jason P | Not found | S | Common Stock | 72 | $33.10 | 847,316.0000 | 0 | 0.01% | 0.00% |
| Nov. 18, 2024 | Incerti Carlo | Not found | M | Stock option (right to buy) | 16500 | $0.00 | 22,693.0000 | 0 | 42.10% | 0.00% |
| Nov. 18, 2024 | Incerti Carlo | Not found | S | Common Stock | 16500 | $28.73 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 14, 2024 | Rhodes Jason P | Not found | S | Common Stock | 4 | $33.10 | 15,962.0000 | 0 | 0.03% | 0.00% |
| Nov. 14, 2024 | Rhodes Jason P | Not found | S | Common Stock | 583 | $33.10 | 5,697,508.0000 | 0 | 0.01% | 0.00% |
| Nov. 18, 2024 | Beskrovnaya Oxana | Chief Scientific Officer | S | Common Stock | 2856 | $28.20 | 137,519.0000 | 0 | 2.03% | 0.00% |
| Nov. 18, 2024 | Scalzo Richard William | SVP, Head of Finance & Admin. | S | Common Stock | 2735 | $28.20 | 95,833.0000 | 0 | 2.77% | 0.00% |
| Nov. 14, 2024 | Rhodes Jason P | Not found | S | Common Stock | 123 | $33.10 | 1,458,568.0000 | 0 | 0.01% | 0.00% |
| Nov. 14, 2024 | Kersten Dirk | Not found | S | Common Stock | 8929 | $32.82 | 5,786,435.0000 | 0 | 0.15% | 0.00% |
| Nov. 13, 2024 | Kersten Dirk | Not found | S | Common Stock | 10803 | $35.24 | 62,301.0000 | 0 | 14.78% | 0.00% |
| Oct. 21, 2024 | Kersten Dirk | Not found | S | Common Stock | 121 | $35.06 | 5,868,468.0000 | 0 | 0.00% | 0.00% |
| Oct. 18, 2024 | Kersten Dirk | Not found | S | Common Stock | 13414 | $35.16 | 5,868,589.0000 | 0 | 0.23% | 0.00% |
| Oct. 16, 2024 | Kersten Dirk | Not found | S | Common Stock | 23671 | $35.35 | 5,895,016.0000 | 0 | 0.40% | 0.00% |
| Oct. 17, 2024 | Kersten Dirk | Not found | S | Common Stock | 13013 | $35.17 | 5,882,003.0000 | 0 | 0.22% | 0.00% |
| Oct. 3, 2024 | Kersten Dirk | Not found | S | Common Stock | 5441 | $35.13 | 5,918,687.0000 | 0 | 0.09% | 0.00% |
| Oct. 2, 2024 | Kersten Dirk | Not found | S | Common Stock | 21518 | $35.38 | 5,924,128.0000 | 0 | 0.36% | 0.00% |
| Oct. 1, 2024 | Kersten Dirk | Not found | S | Common Stock | 8423 | $35.16 | 5,945,646.0000 | 0 | 0.14% | 0.00% |
| Sept. 30, 2024 | Kersten Dirk | Not found | S | Common Stock | 29007 | $35.47 | 5,956,004.0000 | 0 | 0.48% | 0.00% |
| Sept. 27, 2024 | Kersten Dirk | Not found | S | Common Stock | 32 | $35.00 | 5,985,011.0000 | 0 | 0.00% | 0.00% |
| Sept. 30, 2024 | Kersten Dirk | Not found | S | Common Stock | 1935 | $36.02 | 5,954,069.0000 | 0 | 0.03% | 0.00% |
| Sept. 25, 2024 | Kersten Dirk | Not found | S | Common Stock | 2357 | $35.06 | 5,986,303.0000 | 0 | 0.04% | 0.00% |
| Sept. 26, 2024 | Kersten Dirk | Not found | S | Common Stock | 1260 | $35.29 | 5,985,043.0000 | 0 | 0.02% | 0.00% |
| Sept. 20, 2024 | Kersten Dirk | Not found | S | Common Stock | 471 | $37.01 | 6,029,491.0000 | 0 | 0.01% | 0.00% |
| Sept. 23, 2024 | Kersten Dirk | Not found | S | Common Stock | 4610 | $36.33 | 5,988,660.0000 | 0 | 0.08% | 0.00% |
| Sept. 23, 2024 | Kersten Dirk | Not found | S | Common Stock | 36221 | $35.19 | 5,993,270.0000 | 0 | 0.60% | 0.00% |
| Sept. 20, 2024 | Kersten Dirk | Not found | S | Common Stock | 78940 | $36.45 | 6,029,962.0000 | 0 | 1.29% | 0.00% |
| Sept. 19, 2024 | Kersten Dirk | Not found | S | Common Stock | 27767 | $35.74 | 6,159,874.0000 | 0 | 0.45% | 0.00% |
| Sept. 19, 2024 | Kersten Dirk | Not found | S | Common Stock | 50972 | $36.41 | 6,108,902.0000 | 0 | 0.83% | 0.00% |
| Sept. 18, 2024 | Kersten Dirk | Not found | S | Common Stock | 1554 | $35.03 | 6,187,641.0000 | 0 | 0.03% | 0.00% |
| Sept. 18, 2024 | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 4340 | $34.41 | 136,272.0000 | 0 | 3.09% | 0.00% |
| Sept. 18, 2024 | Scalzo Richard William | SVP, Head of Finance & Admin. | S | Common Stock | 1390 | $34.55 | 98,568.0000 | 0 | 1.39% | 0.00% |
| Sept. 18, 2024 | Beskrovnaya Oxana | Chief Scientific Officer | S | Common Stock | 2339 | $34.55 | 140,375.0000 | 0 | 1.64% | 0.00% |
| Sept. 18, 2024 | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 4636 | $34.41 | 131,636.0000 | 0 | 3.40% | 0.00% |
| Sept. 17, 2024 | Kersten Dirk | Not found | S | Common Stock | 3272 | $35.13 | 6,189,195.0000 | 0 | 0.05% | 0.00% |
| Sept. 16, 2024 | Kersten Dirk | Not found | S | Common Stock | 1320 | $35.04 | 6,192,467.0000 | 0 | 0.02% | 0.00% |
| Sept. 11, 2024 | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 2548 | $31.89 | 143,334.0000 | 0 | 1.75% | 0.00% |
| Sept. 11, 2024 | Scalzo Richard William | SVP, Head of Finance & Admin. | S | Common Stock | 1468 | $31.89 | 99,958.0000 | 0 | 1.45% | 0.00% |
| Sept. 11, 2024 | Beskrovnaya Oxana | Chief Scientific Officer | S | Common Stock | 2161 | $31.89 | 142,714.0000 | 0 | 1.49% | 0.00% |
| Sept. 11, 2024 | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 2722 | $31.89 | 140,612.0000 | 0 | 1.90% | 0.00% |
| Sept. 6, 2024 | Scalzo Richard William | SVP, Head of Finance & Admin. | M | Common Stock | 6552 | $10.88 | 227,500.0000 | 0 | 2.97% | 0.00% |
| Sept. 6, 2024 | Scalzo Richard William | SVP, Head of Finance & Admin. | M | Stock option (right to buy) | 6502 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Sept. 6, 2024 | Scalzo Richard William | SVP, Head of Finance & Admin. | M | Stock option (right to buy) | 3353 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Sept. 6, 2024 | Scalzo Richard William | SVP, Head of Finance & Admin. | M | Stock option (right to buy) | 34833 | $0.00 | 742.0000 | 0 | 97.91% | 0.00% |
| Sept. 6, 2024 | Scalzo Richard William | SVP, Head of Finance & Admin. | M | Stock option (right to buy) | 16696 | $0.00 | 8,348.0000 | 0 | 66.67% | 0.00% |
| Sept. 6, 2024 | Scalzo Richard William | SVP, Head of Finance & Admin. | M | Stock option (right to buy) | 29792 | $0.00 | 25,208.0000 | 0 | 54.17% | 0.00% |
| Sept. 6, 2024 | Scalzo Richard William | SVP, Head of Finance & Admin. | M | Stock option (right to buy) | 18750 | $0.00 | 26,250.0000 | 0 | 41.67% | 0.00% |
| Sept. 6, 2024 | Scalzo Richard William | SVP, Head of Finance & Admin. | M | Stock option (right to buy) | 6552 | $0.00 | 28,394.0000 | 0 | 18.75% | 0.00% |
| Sept. 6, 2024 | Scalzo Richard William | SVP, Head of Finance & Admin. | S | Common Stock | 1700 | $32.63 | 101,426.0000 | 0 | 1.65% | 0.00% |
| Sept. 6, 2024 | Scalzo Richard William | SVP, Head of Finance & Admin. | M | Common Stock | 6502 | $5.54 | 117,524.0000 | 0 | 5.86% | 0.00% |
| Sept. 6, 2024 | Scalzo Richard William | SVP, Head of Finance & Admin. | M | Common Stock | 3353 | $5.54 | 120,877.0000 | 0 | 2.85% | 0.00% |
| Sept. 6, 2024 | Scalzo Richard William | SVP, Head of Finance & Admin. | M | Common Stock | 34833 | $19.00 | 155,710.0000 | 0 | 28.82% | 0.00% |
| Sept. 6, 2024 | Scalzo Richard William | SVP, Head of Finance & Admin. | M | Common Stock | 16696 | $13.12 | 172,406.0000 | 0 | 10.72% | 0.00% |
| Sept. 6, 2024 | Scalzo Richard William | SVP, Head of Finance & Admin. | M | Common Stock | 29792 | $8.58 | 202,198.0000 | 0 | 17.28% | 0.00% |
| Sept. 6, 2024 | Scalzo Richard William | SVP, Head of Finance & Admin. | M | Common Stock | 18750 | $10.72 | 220,948.0000 | 0 | 9.27% | 0.00% |
| Sept. 6, 2024 | Scalzo Richard William | SVP, Head of Finance & Admin. | S | Common Stock | 124374 | $32.14 | 103,126.0000 | 0 | 54.67% | 0.00% |
| Sept. 5, 2024 | Kersten Dirk | Not found | S | Common Stock | 1577 | $35.03 | 6,193,787.0000 | 0 | 0.03% | 0.00% |
| Sept. 4, 2024 | Cox John | CEO & President | P | Common Stock | 7200 | $33.09 | 37,000.0000 | 0 | 24.16% | 0.00% |
| Aug. 30, 2024 | Kersten Dirk | Not found | S | Common Stock | 25096 | $45.49 | 6,201,568.0000 | 0 | 0.40% | 0.00% |
| Aug. 30, 2024 | Kersten Dirk | Not found | S | Common Stock | 6204 | $46.01 | 6,195,364.0000 | 0 | 0.10% | 0.00% |
| Sept. 4, 2024 | Cox John | CEO & President | P | Common Stock | 800 | $32.57 | 29,800.0000 | 0 | 2.76% | 0.00% |
| Sept. 4, 2024 | Cox John | CEO & President | P | Common Stock | 800 | $32.57 | 29,800.0000 | 0 | 2.76% | 0.00% |
| Sept. 4, 2024 | Cox John | CEO & President | P | Common Stock | 7200 | $33.09 | 37,000.0000 | 0 | 24.16% | 0.00% |
| Sept. 4, 2024 | Cox John | CEO & President | P | Common Stock | 800 | $32.57 | 29,800.0000 | 0 | 2.76% | 0.00% |
| Sept. 4, 2024 | Cox John | CEO & President | P | Common Stock | 7200 | $33.09 | 37,000.0000 | 0 | 24.16% | 0.00% |
| Sept. 4, 2024 | Cox John | CEO & President | P | Common Stock | 800 | $32.57 | 29,800.0000 | 0 | 2.76% | 0.00% |
| Sept. 4, 2024 | Cox John | CEO & President | P | Common Stock | 7200 | $33.09 | 37,000.0000 | 0 | 24.16% | 0.00% |
| Sept. 3, 2024 | Kerr Douglas | Chief Medical Officer | A | Stock Option (Right to Buy) | 150300 | $0.00 | 150,300.0000 | 0 | 9999.99% | 0.00% |
| Sept. 3, 2024 | Friedl-Naderer Johanna | Chief Commercial Officer | A | Stock Option (Right to Buy) | 185300 | $0.00 | 185,300.0000 | 0 | 9999.99% | 0.00% |
| Sept. 3, 2024 | Friedl-Naderer Johanna | Chief Commercial Officer | A | Common Stock | 58400 | $0.00 | 58,400.0000 | 0 | 9999.99% | 0.00% |
| Sept. 3, 2024 | Kerr Douglas | Chief Medical Officer | A | Common Stock | 47500 | $0.00 | 47,500.0000 | 0 | 9999.99% | 0.00% |
| Aug. 28, 2024 | Kersten Dirk | Not found | S | Common Stock | 16386 | $44.41 | 6,344,539.0000 | 0 | 0.26% | 0.00% |
| Aug. 29, 2024 | Kersten Dirk | Not found | S | Common Stock | 10768 | $45.81 | 6,226,664.0000 | 0 | 0.17% | 0.00% |
| Aug. 29, 2024 | Kersten Dirk | Not found | S | Common Stock | 45640 | $45.19 | 6,237,432.0000 | 0 | 0.73% | 0.00% |
| Aug. 28, 2024 | Kersten Dirk | Not found | S | Common Stock | 61467 | $44.94 | 6,283,072.0000 | 0 | 0.97% | 0.00% |
| Aug. 27, 2024 | Kersten Dirk | Not found | S | Common Stock | 65403 | $44.28 | 6,360,925.0000 | 0 | 1.02% | 0.00% |
| Aug. 26, 2024 | Kersten Dirk | Not found | S | Common Stock | 77963 | $45.23 | 6,437,862.0000 | 0 | 1.20% | 0.00% |
| Aug. 26, 2024 | Kersten Dirk | Not found | S | Common Stock | 11534 | $45.79 | 6,426,328.0000 | 0 | 0.18% | 0.00% |
| Aug. 23, 2024 | Kersten Dirk | Not found | S | Common Stock | 64133 | $46.37 | 6,515,825.0000 | 0 | 0.97% | 0.00% |
| Aug. 22, 2024 | Kersten Dirk | Not found | S | Common Stock | 94908 | $45.82 | 6,601,326.0000 | 0 | 1.42% | 0.00% |
| Aug. 22, 2024 | Kersten Dirk | Not found | S | Common Stock | 413 | $46.97 | 6,600,913.0000 | 0 | 0.01% | 0.00% |
| Aug. 23, 2024 | Kersten Dirk | Not found | S | Common Stock | 20955 | $45.82 | 6,579,958.0000 | 0 | 0.32% | 0.00% |
| Aug. 21, 2024 | Kersten Dirk | Not found | S | Common Stock | 64518 | $46.52 | 6,767,479.0000 | 0 | 0.94% | 0.00% |
| Aug. 20, 2024 | Kersten Dirk | Not found | S | Common Stock | 43057 | $45.68 | 6,875,780.0000 | 0 | 0.62% | 0.00% |
| Aug. 20, 2024 | Kersten Dirk | Not found | S | Common Stock | 35457 | $46.94 | 6,840,323.0000 | 0 | 0.52% | 0.00% |
| Aug. 20, 2024 | Kersten Dirk | Not found | S | Common Stock | 8326 | $47.30 | 6,831,997.0000 | 0 | 0.12% | 0.00% |
| Aug. 21, 2024 | Kersten Dirk | Not found | S | Common Stock | 71245 | $47.01 | 6,696,234.0000 | 0 | 1.05% | 0.00% |
| Aug. 19, 2024 | Kersten Dirk | Not found | S | Common Stock | 30448 | $45.10 | 7,014,421.0000 | 0 | 0.43% | 0.00% |
| Aug. 19, 2024 | Scalzo Richard William | SVP, Head of Finance & Admin. | S | Common Stock | 2442 | $45.01 | 111,332.0000 | 0 | 2.15% | 0.00% |
| Aug. 19, 2024 | Scalzo Richard William | SVP, Head of Finance & Admin. | S | Common Stock | 310 | $46.00 | 111,022.0000 | 0 | 0.28% | 0.00% |
| Aug. 19, 2024 | McNeill Jonathan | Chief Business Officer | S | Common Stock | 2400 | $45.01 | 132,411.0000 | 0 | 1.78% | 0.00% |
| Aug. 19, 2024 | McNeill Jonathan | Chief Business Officer | S | Common Stock | 305 | $46.00 | 132,106.0000 | 0 | 0.23% | 0.00% |
| Aug. 19, 2024 | Farwell Wildon | Chief Medical Officer | S | Common Stock | 2060 | $45.01 | 143,483.0000 | 0 | 1.42% | 0.00% |
| Aug. 19, 2024 | Farwell Wildon | Chief Medical Officer | S | Common Stock | 261 | $46.00 | 143,222.0000 | 0 | 0.18% | 0.00% |
| Aug. 19, 2024 | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 2582 | $45.01 | 146,210.0000 | 0 | 1.74% | 0.00% |
| Aug. 19, 2024 | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 328 | $46.00 | 145,882.0000 | 0 | 0.22% | 0.00% |
| Aug. 19, 2024 | Beskrovnaya Oxana | Chief Scientific Officer | S | Common Stock | 2340 | $45.01 | 145,171.0000 | 0 | 1.59% | 0.00% |
| Aug. 19, 2024 | Beskrovnaya Oxana | Chief Scientific Officer | S | Common Stock | 296 | $46.00 | 144,875.0000 | 0 | 0.20% | 0.00% |
| Aug. 16, 2024 | Kersten Dirk | Not found | S | Common Stock | 34485 | $44.52 | 7,133,027.0000 | 0 | 0.48% | 0.00% |
| Aug. 16, 2024 | Kersten Dirk | Not found | S | Common Stock | 85086 | $45.35 | 7,047,941.0000 | 0 | 1.19% | 0.00% |
| Aug. 16, 2024 | Kersten Dirk | Not found | S | Common Stock | 3072 | $46.19 | 7,044,869.0000 | 0 | 0.04% | 0.00% |
| Aug. 19, 2024 | Kersten Dirk | Not found | S | Common Stock | 89824 | $46.01 | 6,924,597.0000 | 0 | 1.28% | 0.00% |
| Aug. 19, 2024 | Kersten Dirk | Not found | S | Common Stock | 5760 | $46.59 | 6,918,837.0000 | 0 | 0.08% | 0.00% |
| Aug. 15, 2024 | Kersten Dirk | Not found | S | Common Stock | 49601 | $45.67 | 7,167,512.0000 | 0 | 0.69% | 0.00% |
| Aug. 15, 2024 | Kersten Dirk | Not found | S | Common Stock | 131290 | $45.25 | 7,217,113.0000 | 0 | 1.79% | 0.00% |
| Aug. 14, 2024 | Kersten Dirk | Not found | S | Common Stock | 100650 | $43.67 | 7,348,403.0000 | 0 | 1.35% | 0.00% |
| Aug. 8, 2024 | Kersten Dirk | Not found | S | Common Stock | 16357 | $42.97 | 7,822,630.0000 | 0 | 0.21% | 0.00% |
| Aug. 8, 2024 | Kersten Dirk | Not found | S | Common Stock | 68936 | $42.87 | 7,753,694.0000 | 0 | 0.88% | 0.00% |
| Aug. 13, 2024 | Kersten Dirk | Not found | S | Common Stock | 88179 | $42.78 | 7,470,481.0000 | 0 | 1.17% | 0.00% |
| Aug. 13, 2024 | Kersten Dirk | Not found | S | Common Stock | 21428 | $43.57 | 7,449,053.0000 | 0 | 0.29% | 0.00% |
| Aug. 8, 2024 | Kersten Dirk | Not found | S | Common Stock | 6377 | $40.74 | 7,838,987.0000 | 0 | 0.08% | 0.00% |
| Aug. 9, 2024 | Kersten Dirk | Not found | S | Common Stock | 1160 | $44.04 | 7,661,530.0000 | 0 | 0.02% | 0.00% |
| Aug. 9, 2024 | Kersten Dirk | Not found | S | Common Stock | 40268 | $43.44 | 7,662,690.0000 | 0 | 0.52% | 0.00% |
| Aug. 9, 2024 | Kersten Dirk | Not found | S | Common Stock | 50736 | $42.55 | 7,702,958.0000 | 0 | 0.65% | 0.00% |
| Aug. 12, 2024 | Kersten Dirk | Not found | S | Common Stock | 26416 | $42.74 | 7,635,114.0000 | 0 | 0.34% | 0.00% |
| Aug. 12, 2024 | Kersten Dirk | Not found | S | Common Stock | 52076 | $43.42 | 7,583,038.0000 | 0 | 0.68% | 0.00% |
| Aug. 13, 2024 | Kersten Dirk | Not found | S | Common Stock | 24378 | $42.08 | 7,558,660.0000 | 0 | 0.32% | 0.00% |
| Aug. 8, 2024 | Kersten Dirk | Not found | S | Common Stock | 68936 | $42.87 | 7,753,694.0000 | 0 | 0.88% | 0.00% |
| Aug. 8, 2024 | Kersten Dirk | Not found | S | Common Stock | 16357 | $42.97 | 7,822,630.0000 | 0 | 0.21% | 0.00% |
| Aug. 8, 2024 | Kersten Dirk | Not found | S | Common Stock | 6377 | $40.74 | 7,838,987.0000 | 0 | 0.08% | 0.00% |
| Aug. 9, 2024 | Kersten Dirk | Not found | S | Common Stock | 50736 | $42.55 | 7,702,958.0000 | 0 | 0.65% | 0.00% |
| Aug. 9, 2024 | Kersten Dirk | Not found | S | Common Stock | 40268 | $43.44 | 7,662,690.0000 | 0 | 0.52% | 0.00% |
| Aug. 9, 2024 | Kersten Dirk | Not found | S | Common Stock | 1160 | $44.04 | 7,661,530.0000 | 0 | 0.02% | 0.00% |
| June 24, 2024 | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 10213 | $35.33 | 148,792.0000 | 0 | 6.42% | 0.00% |
| June 21, 2024 | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 29787 | $35.01 | 148,792.0000 | 0 | 16.68% | 0.00% |
| June 21, 2024 | HIGH SUSANNA GATTI | Chief Operating Officer | M | Common Stock | 29787 | $5.54 | 178,579.0000 | 0 | 20.02% | 0.00% |
| June 24, 2024 | HIGH SUSANNA GATTI | Chief Operating Officer | M | Stock option (right to buy) | 10213 | $0.00 | 60,486.0000 | 0 | 14.45% | 0.00% |
| June 21, 2024 | HIGH SUSANNA GATTI | Chief Operating Officer | M | Stock option (right to buy) | 29787 | $0.00 | 70,699.0000 | 0 | 29.64% | 0.00% |
| June 24, 2024 | HIGH SUSANNA GATTI | Chief Operating Officer | M | Common Stock | 10213 | $5.54 | 159,005.0000 | 0 | 6.86% | 0.00% |
| June 21, 2024 | HIGH SUSANNA GATTI | Chief Operating Officer | M | Common Stock | 29787 | $5.54 | 178,579.0000 | 0 | 20.02% | 0.00% |
| June 24, 2024 | HIGH SUSANNA GATTI | Chief Operating Officer | M | Common Stock | 10163 | $5.54 | 158,955.0000 | 0 | 6.83% | 0.00% |
| June 24, 2024 | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 10163 | $35.33 | 148,792.0000 | 0 | 6.39% | 0.00% |
| June 21, 2024 | HIGH SUSANNA GATTI | Chief Operating Officer | M | Stock option (right to buy) | 29787 | $0.00 | 70,699.0000 | 0 | 29.64% | 0.00% |
| June 24, 2024 | HIGH SUSANNA GATTI | Chief Operating Officer | M | Stock option (right to buy) | 10163 | $0.00 | 60,536.0000 | 0 | 14.38% | 0.00% |
| June 21, 2024 | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 29787 | $35.01 | 148,792.0000 | 0 | 16.68% | 0.00% |
| June 12, 2024 | HIGH SUSANNA GATTI | Chief Operating Officer | M | Stock option (right to buy) | 40000 | $0.00 | 100,486.0000 | 0 | 28.47% | 0.00% |
| June 12, 2024 | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 13964 | $33.70 | 148,792.0000 | 0 | 8.58% | 0.00% |
| June 12, 2024 | HIGH SUSANNA GATTI | Chief Operating Officer | M | Common Stock | 40000 | $5.54 | 188,792.0000 | 0 | 26.88% | 0.00% |
| June 12, 2024 | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 26036 | $33.17 | 162,756.0000 | 0 | 13.79% | 0.00% |
| June 11, 2024 | Beskrovnaya Oxana | Chief Scientific Officer | S | Common Stock | 2136 | $31.34 | 147,511.0000 | 0 | 1.43% | 0.00% |
| June 11, 2024 | Farwell Wildon | Chief Medical Officer | S | Common Stock | 1628 | $31.27 | 146,551.0000 | 0 | 1.10% | 0.00% |
| June 11, 2024 | Farwell Wildon | Chief Medical Officer | S | Common Stock | 1008 | $31.27 | 145,543.0000 | 0 | 0.69% | 0.00% |
| June 10, 2024 | HIGH SUSANNA GATTI | Chief Operating Officer | M | Common Stock | 80000 | $5.54 | 234,062.0000 | 0 | 51.93% | 0.00% |
| June 10, 2024 | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 80000 | $30.24 | 154,062.0000 | 0 | 34.18% | 0.00% |
| June 11, 2024 | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 2357 | $31.23 | 151,705.0000 | 0 | 1.53% | 0.00% |
| June 11, 2024 | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 2913 | $31.23 | 148,792.0000 | 0 | 1.92% | 0.00% |
| June 11, 2024 | Scalzo Richard William | SVP, Head of Finance & Admin. | S | Common Stock | 1331 | $31.34 | 113,774.0000 | 0 | 1.16% | 0.00% |
| June 10, 2024 | Scalzo Richard William | SVP, Head of Finance & Admin. | S | Common Stock | 1590 | $30.23 | 115,105.0000 | 0 | 1.36% | 0.00% |
| June 11, 2024 | McNeill Jonathan | Chief Business Officer | S | Common Stock | 1823 | $31.34 | 134,811.0000 | 0 | 1.33% | 0.00% |
| June 10, 2024 | HIGH SUSANNA GATTI | Chief Operating Officer | M | Stock option (right to buy) | 80000 | $0.00 | 140,486.0000 | 0 | 36.28% | 0.00% |
| May 22, 2024 | Incerti Carlo | Not found | A | Stock option (right to buy) | 25133 | $0.00 | 25,133.0000 | 0 | 9999.99% | 0.00% |
| May 22, 2024 | Lubner David Charles | Not found | A | Stock option (right to buy) | 25133 | $0.00 | 25,133.0000 | 0 | 9999.99% | 0.00% |
| May 22, 2024 | Rhodes Jason P | Not found | A | Stock option (right to buy) | 25133 | $0.00 | 25,133.0000 | 0 | 9999.99% | 0.00% |
| May 22, 2024 | HURWITZ EDWARD | Not found | A | Stock option (right to buy) | 25133 | $0.00 | 25,133.0000 | 0 | 9999.99% | 0.00% |
| May 22, 2024 | Kersten Dirk | Not found | A | Stock option (right to buy) | 25133 | $0.00 | 25,133.0000 | 0 | 9999.99% | 0.00% |
| May 22, 2024 | Stehman-Breen Catherine | Not found | A | Stock option (right to buy) | 25133 | $0.00 | 25,133.0000 | 0 | 9999.99% | 0.00% |
| May 20, 2024 | Beskrovnaya Oxana | Chief Scientific Officer | M | Stock option (right to buy) | 30426 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 20, 2024 | Beskrovnaya Oxana | Chief Scientific Officer | S | Common Stock | 12147 | $33.51 | 150,792.0000 | 0 | 7.45% | 0.00% |
| May 20, 2024 | Beskrovnaya Oxana | Chief Scientific Officer | S | Common Stock | 17134 | $32.49 | 162,939.0000 | 0 | 9.52% | 0.00% |
| May 20, 2024 | Beskrovnaya Oxana | Chief Scientific Officer | M | Common Stock | 30426 | $1.03 | 180,073.0000 | 0 | 20.33% | 0.00% |
| May 20, 2024 | Beskrovnaya Oxana | Chief Scientific Officer | S | Common Stock | 1145 | $34.08 | 149,647.0000 | 0 | 0.76% | 0.00% |
| May 16, 2024 | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 2249 | $28.20 | 154,551.0000 | 0 | 1.43% | 0.00% |
| May 16, 2024 | Beskrovnaya Oxana | Chief Scientific Officer | S | Common Stock | 2222 | $28.20 | 150,130.0000 | 0 | 1.46% | 0.00% |
| May 16, 2024 | Beskrovnaya Oxana | Chief Scientific Officer | S | Common Stock | 483 | $28.59 | 149,647.0000 | 0 | 0.32% | 0.00% |
| May 16, 2024 | Farwell Wildon | Chief Medical Officer | S | Common Stock | 1956 | $28.20 | 148,604.0000 | 0 | 1.30% | 0.00% |
| May 16, 2024 | Farwell Wildon | Chief Medical Officer | S | Common Stock | 425 | $28.59 | 148,179.0000 | 0 | 0.29% | 0.00% |
| May 16, 2024 | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 489 | $28.59 | 154,062.0000 | 0 | 0.32% | 0.00% |
| May 16, 2024 | Scalzo Richard William | SVP, Head of Finance & Admin. | S | Common Stock | 2126 | $28.20 | 117,157.0000 | 0 | 1.78% | 0.00% |
| May 16, 2024 | Scalzo Richard William | SVP, Head of Finance & Admin. | S | Common Stock | 462 | $28.59 | 116,695.0000 | 0 | 0.39% | 0.00% |
| May 16, 2024 | McNeill Jonathan | Chief Business Officer | S | Common Stock | 2279 | $28.20 | 137,129.0000 | 0 | 1.63% | 0.00% |
| May 16, 2024 | McNeill Jonathan | Chief Business Officer | S | Common Stock | 495 | $28.59 | 136,634.0000 | 0 | 0.36% | 0.00% |
| July 11, 2023 | McNeill Jonathan | Chief Business Officer | A | Stock option (right to buy) | 35000 | $0.00 | 35,000.0000 | 0 | 9999.99% | 0.00% |
| March 25, 2024 | Cox John | See Remarks | A | Stock Option (Right to Buy) | 679853 | $0.00 | 679,853.0000 | 0 | 9999.99% | 0.00% |
| March 8, 2024 | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 26908 | $26.66 | 159,383.0000 | 0 | 14.44% | 0.00% |
| March 8, 2024 | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 291 | $27.41 | 159,092.0000 | 0 | 0.18% | 0.00% |
| March 11, 2024 | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 2292 | $25.70 | 156,800.0000 | 0 | 1.44% | 0.00% |
| March 8, 2024 | McNeill Jonathan | Chief Business Officer | M | Common Stock | 3841 | $5.54 | 231,184.0000 | 0 | 1.69% | 0.00% |
| March 8, 2024 | McNeill Jonathan | Chief Business Officer | M | Common Stock | 86159 | $5.54 | 227,343.0000 | 0 | 61.03% | 0.00% |
| March 11, 2024 | McNeill Jonathan | Chief Business Officer | M | Stock option (right to buy) | 17825 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 8, 2024 | McNeill Jonathan | Chief Business Officer | M | Stock option (right to buy) | 3841 | $0.00 | 17,825.0000 | 0 | 17.73% | 0.00% |
| March 8, 2024 | McNeill Jonathan | Chief Business Officer | M | Stock option (right to buy) | 86159 | $0.00 | 12,309.0000 | 0 | 87.50% | 0.00% |
| March 11, 2024 | McNeill Jonathan | Chief Business Officer | S | Common Stock | 1776 | $25.71 | 139,408.0000 | 0 | 1.26% | 0.00% |
| March 11, 2024 | McNeill Jonathan | Chief Business Officer | S | Common Stock | 17825 | $25.48 | 141,184.0000 | 0 | 11.21% | 0.00% |
| March 11, 2024 | McNeill Jonathan | Chief Business Officer | M | Common Stock | 17825 | $5.54 | 159,009.0000 | 0 | 12.63% | 0.00% |
| March 8, 2024 | McNeill Jonathan | Chief Business Officer | S | Common Stock | 689 | $27.31 | 141,184.0000 | 0 | 0.49% | 0.00% |
| March 8, 2024 | McNeill Jonathan | Chief Business Officer | S | Common Stock | 54648 | $26.72 | 141,873.0000 | 0 | 27.81% | 0.00% |
| March 8, 2024 | McNeill Jonathan | Chief Business Officer | S | Common Stock | 34663 | $25.46 | 196,521.0000 | 0 | 14.99% | 0.00% |
| March 8, 2024 | Scalzo Richard William | SVP, Head of Finance & Admin. | M | Stock option (right to buy) | 68919 | $0.00 | 9,855.0000 | 0 | 87.49% | 0.00% |
| March 11, 2024 | Scalzo Richard William | SVP, Head of Finance & Admin. | S | Common Stock | 1590 | $24.99 | 119,283.0000 | 0 | 1.32% | 0.00% |
| March 11, 2024 | Scalzo Richard William | SVP, Head of Finance & Admin. | S | Common Stock | 1082 | $25.70 | 120,873.0000 | 0 | 0.89% | 0.00% |
| March 8, 2024 | Scalzo Richard William | SVP, Head of Finance & Admin. | S | Common Stock | 289 | $27.33 | 121,955.0000 | 0 | 0.24% | 0.00% |
| March 8, 2024 | Scalzo Richard William | SVP, Head of Finance & Admin. | S | Common Stock | 55208 | $26.72 | 122,244.0000 | 0 | 31.11% | 0.00% |
| March 8, 2024 | Scalzo Richard William | SVP, Head of Finance & Admin. | S | Common Stock | 30755 | $25.31 | 177,452.0000 | 0 | 14.77% | 0.00% |
| March 8, 2024 | Scalzo Richard William | SVP, Head of Finance & Admin. | M | Common Stock | 17333 | $5.54 | 208,207.0000 | 0 | 9.08% | 0.00% |
| March 8, 2024 | Scalzo Richard William | SVP, Head of Finance & Admin. | M | Common Stock | 68919 | $5.54 | 190,874.0000 | 0 | 56.51% | 0.00% |
| March 11, 2024 | Farwell Wildon | Chief Medical Officer | S | Common Stock | 1585 | $25.70 | 151,590.0000 | 0 | 1.03% | 0.00% |
| March 12, 2024 | Farwell Wildon | Chief Medical Officer | S | Common Stock | 1030 | $25.58 | 150,560.0000 | 0 | 0.68% | 0.00% |
| March 11, 2024 | Beskrovnaya Oxana | Chief Scientific Officer | S | Common Stock | 2081 | $25.70 | 152,352.0000 | 0 | 1.35% | 0.00% |
| March 11, 2024 | Brumm Joshua T | CEO & President | M | Stock option (right to buy) | 50000 | $0.00 | 83,269.0000 | 0 | 37.52% | 0.00% |
| March 8, 2024 | Brumm Joshua T | CEO & President | M | Stock option (right to buy) | 209412 | $0.00 | 133,269.0000 | 0 | 61.11% | 0.00% |
| March 8, 2024 | Brumm Joshua T | CEO & President | M | Stock option (right to buy) | 153931 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 11, 2024 | Brumm Joshua T | CEO & President | S | Common Stock | 8618 | $25.93 | 537,998.0000 | 0 | 1.58% | 0.00% |
| March 11, 2024 | Brumm Joshua T | CEO & President | S | Common Stock | 7769 | $26.12 | 546,616.0000 | 0 | 1.40% | 0.00% |
| March 11, 2024 | Brumm Joshua T | CEO & President | S | Common Stock | 9928 | $26.10 | 554,385.0000 | 0 | 1.76% | 0.00% |
| March 11, 2024 | Brumm Joshua T | CEO & President | S | Common Stock | 40072 | $25.42 | 564,313.0000 | 0 | 6.63% | 0.00% |
| March 11, 2024 | Brumm Joshua T | CEO & President | M | Common Stock | 50000 | $5.54 | 604,385.0000 | 0 | 9.02% | 0.00% |
| March 8, 2024 | Brumm Joshua T | CEO & President | S | Common Stock | 435 | $27.38 | 554,385.0000 | 0 | 0.08% | 0.00% |
| March 8, 2024 | Brumm Joshua T | CEO & President | S | Common Stock | 160670 | $26.72 | 554,820.0000 | 0 | 22.46% | 0.00% |
| March 8, 2024 | Brumm Joshua T | CEO & President | S | Common Stock | 202238 | $25.30 | 715,490.0000 | 0 | 22.04% | 0.00% |
| March 8, 2024 | Brumm Joshua T | CEO & President | M | Common Stock | 209412 | $5.54 | 917,728.0000 | 0 | 29.56% | 0.00% |
| March 8, 2024 | Brumm Joshua T | CEO & President | M | Common Stock | 153931 | $5.54 | 708,316.0000 | 0 | 27.77% | 0.00% |
| March 8, 2024 | Scalzo Richard William | SVP, Head of Finance & Admin. | M | Stock option (right to buy) | 17333 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 7, 2024 | Scalzo Richard William | SVP, Head of Finance & Admin. | S | Common Stock | 2273 | $25.85 | 121,955.0000 | 0 | 1.83% | 0.00% |
| March 7, 2024 | Brumm Joshua T | CEO & President | S | Common Stock | 9086 | $25.85 | 554,385.0000 | 0 | 1.61% | 0.00% |
| March 7, 2024 | Beskrovnaya Oxana | Chief Scientific Officer | S | Common Stock | 2373 | $25.85 | 154,433.0000 | 0 | 1.51% | 0.00% |
| March 7, 2024 | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 1591 | $25.85 | 186,291.0000 | 0 | 0.85% | 0.00% |
| March 7, 2024 | Farwell Wildon | Chief Medical Officer | S | Common Stock | 8364 | $25.80 | 154,732.0000 | 0 | 5.13% | 0.00% |
| March 7, 2024 | Farwell Wildon | Chief Medical Officer | S | Common Stock | 1557 | $26.20 | 153,175.0000 | 0 | 1.01% | 0.00% |
| March 7, 2024 | McNeill Jonathan | Chief Business Officer | S | Common Stock | 2434 | $25.85 | 141,184.0000 | 0 | 1.69% | 0.00% |
| March 1, 2024 | Rhodes Jason P | Not found | S | Common Stock | 29435 | $30.05 | 7,156,782.0000 | 0 | 0.41% | 0.00% |
| March 1, 2024 | Rhodes Jason P | Not found | S | Common Stock | 17099 | $30.05 | 6,545,479.0000 | 0 | 0.26% | 0.00% |
| March 1, 2024 | Atlas Venture Opportunity Fund I, L.P. | Not found | S | Common Stock | 29435 | $30.05 | 2,306,079.0000 | 0 | 1.26% | 0.00% |
| March 1, 2024 | Atlas Venture Opportunity Fund I, L.P. | Not found | S | Common Stock | 17099 | $30.05 | 2,306,079.0000 | 0 | 0.74% | 0.00% |
| March 1, 2024 | McNeill Jonathan | Chief Business Officer | S | Common Stock | 14103 | $28.25 | 153,775.0000 | 0 | 8.40% | 0.00% |
| March 1, 2024 | McNeill Jonathan | Chief Business Officer | S | Common Stock | 8715 | $29.06 | 145,060.0000 | 0 | 5.67% | 0.00% |
| March 1, 2024 | McNeill Jonathan | Chief Business Officer | S | Common Stock | 1442 | $29.70 | 143,618.0000 | 0 | 0.99% | 0.00% |
| Feb. 29, 2024 | McNeill Jonathan | Chief Business Officer | M | Stock option (right to buy) | 4268 | $0.00 | 24,260.0000 | 0 | 14.96% | 0.00% |
| March 1, 2024 | McNeill Jonathan | Chief Business Officer | M | Stock option (right to buy) | 24260 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 29, 2024 | Scalzo Richard William | SVP, Head of Finance & Admin. | M | Common Stock | 3429 | $1.03 | 127,657.0000 | 0 | 2.76% | 0.00% |
| Feb. 29, 2024 | Scalzo Richard William | SVP, Head of Finance & Admin. | S | Common Stock | 3429 | $27.50 | 124,228.0000 | 0 | 2.69% | 0.00% |
| March 1, 2024 | Scalzo Richard William | SVP, Head of Finance & Admin. | M | Common Stock | 9311 | $1.03 | 133,539.0000 | 0 | 7.50% | 0.00% |
| March 1, 2024 | Scalzo Richard William | SVP, Head of Finance & Admin. | S | Common Stock | 8747 | $28.22 | 124,792.0000 | 0 | 6.55% | 0.00% |
| March 1, 2024 | Scalzo Richard William | SVP, Head of Finance & Admin. | S | Common Stock | 564 | $28.65 | 124,228.0000 | 0 | 0.45% | 0.00% |
| Feb. 29, 2024 | Scalzo Richard William | SVP, Head of Finance & Admin. | M | Stock option (right to buy) | 3429 | $0.00 | 9,311.0000 | 0 | 26.92% | 0.00% |
| March 1, 2024 | Scalzo Richard William | SVP, Head of Finance & Admin. | M | Stock option (right to buy) | 9311 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 29, 2024 | Brumm Joshua T | CEO & President | M | Common Stock | 5520 | $5.54 | 568,991.0000 | 0 | 0.98% | 0.00% |
| Feb. 29, 2024 | Brumm Joshua T | CEO & President | S | Common Stock | 5520 | $27.50 | 563,471.0000 | 0 | 0.97% | 0.00% |
| March 1, 2024 | Brumm Joshua T | CEO & President | M | Common Stock | 94480 | $5.54 | 657,951.0000 | 0 | 16.77% | 0.00% |
| March 1, 2024 | Brumm Joshua T | CEO & President | S | Common Stock | 18976 | $28.25 | 638,975.0000 | 0 | 2.88% | 0.00% |
| March 1, 2024 | Brumm Joshua T | CEO & President | S | Common Stock | 74090 | $29.23 | 564,885.0000 | 0 | 11.60% | 0.00% |
| March 1, 2024 | Brumm Joshua T | CEO & President | S | Common Stock | 1414 | $29.70 | 563,471.0000 | 0 | 0.25% | 0.00% |
| Feb. 29, 2024 | Brumm Joshua T | CEO & President | M | Stock option (right to buy) | 5520 | $0.00 | 102,343.0000 | 0 | 5.12% | 0.00% |
| March 1, 2024 | Brumm Joshua T | CEO & President | M | Stock option (right to buy) | 57843 | $0.00 | 44,500.0000 | 0 | 56.52% | 0.00% |
| March 1, 2024 | Brumm Joshua T | CEO & President | M | Stock option (right to buy) | 36637 | $0.00 | 342,681.0000 | 0 | 9.66% | 0.00% |
| Feb. 29, 2024 | McNeill Jonathan | Chief Business Officer | M | Common Stock | 4268 | $0.73 | 147,886.0000 | 0 | 2.97% | 0.00% |
| Feb. 29, 2024 | McNeill Jonathan | Chief Business Officer | S | Common Stock | 4268 | $27.50 | 143,618.0000 | 0 | 2.89% | 0.00% |
| March 1, 2024 | McNeill Jonathan | Chief Business Officer | M | Common Stock | 24260 | $0.73 | 167,878.0000 | 0 | 16.89% | 0.00% |
| Feb. 27, 2024 | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 272923 | $24.38 | 6,743,031.0000 | 0 | 3.89% | 0.00% |
| Feb. 26, 2024 | Rhodes Jason P | Not found | S | Common Stock | 136312 | $23.59 | 6,216,250.0000 | 0 | 2.15% | 0.00% |
| Feb. 26, 2024 | Rhodes Jason P | Not found | S | Common Stock | 64783 | $23.98 | 6,151,467.0000 | 0 | 1.04% | 0.00% |
| Feb. 26, 2024 | Rhodes Jason P | Not found | S | Common Stock | 20205 | $23.59 | 1,564,932.0000 | 0 | 1.27% | 0.00% |
| Feb. 26, 2024 | Rhodes Jason P | Not found | S | Common Stock | 9603 | $23.98 | 1,555,329.0000 | 0 | 0.61% | 0.00% |
| Feb. 26, 2024 | Rhodes Jason P | Not found | S | Common Stock | 11736 | $23.59 | 909,107.0000 | 0 | 1.27% | 0.00% |
| Feb. 26, 2024 | Rhodes Jason P | Not found | S | Common Stock | 5580 | $23.98 | 903,527.0000 | 0 | 0.61% | 0.00% |
| Feb. 27, 2024 | Rhodes Jason P | Not found | S | Common Stock | 272923 | $24.38 | 5,878,544.0000 | 0 | 4.44% | 0.00% |
| Feb. 27, 2024 | Rhodes Jason P | Not found | S | Common Stock | 25779 | $24.68 | 5,852,765.0000 | 0 | 0.44% | 0.00% |
| Feb. 27, 2024 | Rhodes Jason P | Not found | S | Common Stock | 40455 | $24.38 | 1,514,874.0000 | 0 | 2.60% | 0.00% |
| Feb. 27, 2024 | Rhodes Jason P | Not found | S | Common Stock | 3821 | $24.68 | 1,511,053.0000 | 0 | 0.25% | 0.00% |
| Feb. 27, 2024 | Rhodes Jason P | Not found | S | Common Stock | 23505 | $24.38 | 880,022.0000 | 0 | 2.60% | 0.00% |
| Feb. 28, 2024 | Rhodes Jason P | Not found | S | Common Stock | 152244 | $24.83 | 5,700,521.0000 | 0 | 2.60% | 0.00% |
| Feb. 27, 2024 | Rhodes Jason P | Not found | S | Common Stock | 2216 | $24.68 | 877,806.0000 | 0 | 0.25% | 0.00% |
| Feb. 28, 2024 | Rhodes Jason P | Not found | S | Common Stock | 2430 | $25.25 | 5,698,091.0000 | 0 | 0.04% | 0.00% |
| Feb. 28, 2024 | Rhodes Jason P | Not found | S | Common Stock | 22567 | $24.83 | 1,488,486.0000 | 0 | 1.49% | 0.00% |
| Feb. 28, 2024 | Rhodes Jason P | Not found | S | Common Stock | 360 | $25.25 | 1,488,126.0000 | 0 | 0.02% | 0.00% |
| Feb. 28, 2024 | Rhodes Jason P | Not found | S | Common Stock | 13109 | $24.83 | 864,697.0000 | 0 | 1.49% | 0.00% |
| Feb. 28, 2024 | Rhodes Jason P | Not found | S | Common Stock | 210 | $25.25 | 864,487.0000 | 0 | 0.02% | 0.00% |
| Feb. 26, 2024 | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 136312 | $23.59 | 7,080,737.0000 | 0 | 1.89% | 0.00% |
| Feb. 26, 2024 | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 64783 | $23.98 | 7,015,954.0000 | 0 | 0.91% | 0.00% |
| Feb. 26, 2024 | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 20205 | $23.59 | 7,263,023.0000 | 0 | 0.28% | 0.00% |
| Feb. 26, 2024 | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 9603 | $23.98 | 7,253,420.0000 | 0 | 0.13% | 0.00% |
| Feb. 26, 2024 | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 11736 | $23.59 | 6,607,198.0000 | 0 | 0.18% | 0.00% |
| Feb. 26, 2024 | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 5580 | $23.98 | 6,601,618.0000 | 0 | 0.08% | 0.00% |
| Feb. 28, 2024 | Farwell Wildon | Chief Medical Officer | S | Common Stock | 407 | $25.00 | 163,096.0000 | 0 | 0.25% | 0.00% |
| Feb. 27, 2024 | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 25779 | $24.68 | 6,717,252.0000 | 0 | 0.38% | 0.00% |
| Feb. 27, 2024 | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 40455 | $24.38 | 7,212,965.0000 | 0 | 0.56% | 0.00% |
| Feb. 27, 2024 | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 3821 | $24.68 | 7,209,144.0000 | 0 | 0.05% | 0.00% |
| Feb. 27, 2024 | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 23505 | $24.38 | 6,578,113.0000 | 0 | 0.36% | 0.00% |
| Feb. 27, 2024 | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 2216 | $24.68 | 6,575,897.0000 | 0 | 0.03% | 0.00% |
| Feb. 28, 2024 | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 152244 | $24.83 | 6,565,008.0000 | 0 | 2.27% | 0.00% |
| Feb. 28, 2024 | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 2430 | $25.25 | 6,562,578.0000 | 0 | 0.04% | 0.00% |
| Feb. 28, 2024 | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 22567 | $24.83 | 7,186,577.0000 | 0 | 0.31% | 0.00% |
| Feb. 28, 2024 | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 360 | $25.25 | 7,186,217.0000 | 0 | 0.01% | 0.00% |
| Feb. 28, 2024 | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 13109 | $24.83 | 6,562,788.0000 | 0 | 0.20% | 0.00% |
| Feb. 28, 2024 | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 210 | $25.25 | 6,562,578.0000 | 0 | 0.00% | 0.00% |
| Feb. 23, 2024 | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 13738 | $22.70 | 7,273,405.0000 | 0 | 0.19% | 0.00% |
| Feb. 21, 2024 | Rhodes Jason P | Not found | S | Common Stock | 149337 | $22.44 | 6,666,628.0000 | 0 | 2.19% | 0.00% |
| Feb. 21, 2024 | Rhodes Jason P | Not found | S | Common Stock | 35164 | $23.14 | 6,631,464.0000 | 0 | 0.53% | 0.00% |
| Feb. 22, 2024 | Rhodes Jason P | Not found | S | Common Stock | 119360 | $22.66 | 6,512,104.0000 | 0 | 1.80% | 0.00% |
| Feb. 23, 2024 | Rhodes Jason P | Not found | S | Common Stock | 159542 | $22.70 | 6,352,562.0000 | 0 | 2.45% | 0.00% |
| Feb. 23, 2024 | Rhodes Jason P | Not found | S | Common Stock | 23648 | $22.70 | 1,585,137.0000 | 0 | 1.47% | 0.00% |
| Feb. 23, 2024 | Rhodes Jason P | Not found | S | Common Stock | 13738 | $22.70 | 920,843.0000 | 0 | 1.47% | 0.00% |
| Feb. 21, 2024 | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 149337 | $22.44 | 7,587,471.0000 | 0 | 1.93% | 0.00% |
| Feb. 21, 2024 | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 35164 | $23.14 | 7,552,307.0000 | 0 | 0.46% | 0.00% |
| Feb. 22, 2024 | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 119360 | $22.66 | 7,432,947.0000 | 0 | 1.58% | 0.00% |
| Feb. 23, 2024 | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 159542 | $22.70 | 7,273,405.0000 | 0 | 2.15% | 0.00% |
| Feb. 23, 2024 | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 23648 | $22.70 | 7,937,699.0000 | 0 | 0.30% | 0.00% |
| Feb. 20, 2024 | Rhodes Jason P | Not found | S | Common Stock | 3510 | $23.40 | 9,359,331.0000 | 0 | 0.04% | 0.00% |
| Feb. 15, 2024 | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 175793 | $23.88 | 7,150,324.0000 | 0 | 2.40% | 0.00% |
| Feb. 15, 2024 | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 2113 | $24.45 | 7,148,211.0000 | 0 | 0.03% | 0.00% |
| Feb. 16, 2024 | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 162707 | $23.14 | 6,985,504.0000 | 0 | 2.28% | 0.00% |
| Feb. 20, 2024 | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 166029 | $22.71 | 6,819,475.0000 | 0 | 2.38% | 0.00% |
| Feb. 20, 2024 | Atlas Venture Fund XI, L.P. | Not found | S | Common Stock | 3510 | $23.40 | 6,815,965.0000 | 0 | 0.05% | 0.00% |
| Feb. 15, 2024 | Rhodes Jason P | Not found | S | Common Stock | 175793 | $23.88 | 9,693,690.0000 | 0 | 1.78% | 0.00% |
| Feb. 15, 2024 | Rhodes Jason P | Not found | S | Common Stock | 2113 | $24.45 | 9,691,577.0000 | 0 | 0.02% | 0.00% |
| Feb. 16, 2024 | Rhodes Jason P | Not found | S | Common Stock | 162707 | $23.14 | 9,528,870.0000 | 0 | 1.68% | 0.00% |
| Feb. 20, 2024 | Rhodes Jason P | Not found | S | Common Stock | 166029 | $22.71 | 9,362,841.0000 | 0 | 1.74% | 0.00% |
| Feb. 12, 2024 | Farwell Wildon | Chief Medical Officer | S | Common Stock | 5493 | $25.07 | 163,503.0000 | 0 | 3.25% | 0.00% |
| Jan. 29, 2024 | Brumm Joshua T | CEO & President | G | Common Stock | 1500 | $0.00 | 563,471.0000 | 0 | 0.27% | 0.00% |
| Jan. 29, 2024 | Brumm Joshua T | CEO & President | G | Common Stock | 20000 | $0.00 | 564,971.0000 | 0 | 3.42% | 0.00% |
| Jan. 26, 2024 | McNeill Jonathan | Chief Business Officer | M | Stock option (right to buy) | 20000 | $0.00 | 28,528.0000 | 0 | 41.21% | 0.00% |
| Jan. 26, 2024 | Scalzo Richard William | SVP, Head of Finance & Admin. | M | Common Stock | 13000 | $1.03 | 137,228.0000 | 0 | 10.46% | 0.00% |
| Jan. 26, 2024 | Scalzo Richard William | SVP, Head of Finance & Admin. | S | Common Stock | 13000 | $24.34 | 124,228.0000 | 0 | 9.47% | 0.00% |
| Jan. 26, 2024 | Scalzo Richard William | SVP, Head of Finance & Admin. | M | Stock option (right to buy) | 13000 | $0.00 | 12,740.0000 | 0 | 50.51% | 0.00% |
| Jan. 26, 2024 | Farwell Wildon | Chief Medical Officer | S | Common Stock | 100 | $25.00 | 168,996.0000 | 0 | 0.06% | 0.00% |
| Jan. 26, 2024 | McNeill Jonathan | Chief Business Officer | S | Common Stock | 19822 | $24.52 | 143,796.0000 | 0 | 12.11% | 0.00% |
| Jan. 26, 2024 | McNeill Jonathan | Chief Business Officer | S | Common Stock | 178 | $25.14 | 143,618.0000 | 0 | 0.12% | 0.00% |
| Jan. 26, 2024 | McNeill Jonathan | Chief Business Officer | M | Common Stock | 20000 | $0.73 | 163,618.0000 | 0 | 13.93% | 0.00% |
| Jan. 9, 2024 | Kersten Dirk | Not found | P | Common Stock | 285714 | $17.50 | 6,416,793.0000 | 0 | 4.66% | 0.00% |
| Jan. 9, 2024 | Kersten Dirk | Not found | P | Common Stock | 1428571 | $17.50 | 1,428,571.0000 | 0 | 9999.99% | 0.00% |
| Jan. 3, 2024 | Beskrovnaya Oxana | Chief Scientific Officer | M | Common Stock | 45326 | $1.03 | 221,911.0000 | 0 | 25.67% | 0.00% |
| Jan. 3, 2024 | Beskrovnaya Oxana | Chief Scientific Officer | S | Common Stock | 24583 | $19.05 | 181,946.0000 | 0 | 11.90% | 0.00% |
| Jan. 3, 2024 | Beskrovnaya Oxana | Chief Scientific Officer | S | Common Stock | 5361 | $20.50 | 176,585.0000 | 0 | 2.95% | 0.00% |
| Jan. 4, 2024 | Beskrovnaya Oxana | Chief Scientific Officer | M | Common Stock | 22674 | $1.03 | 199,259.0000 | 0 | 12.84% | 0.00% |
| Jan. 4, 2024 | Beskrovnaya Oxana | Chief Scientific Officer | S | Common Stock | 42453 | $18.13 | 156,806.0000 | 0 | 21.31% | 0.00% |
| Jan. 3, 2024 | Beskrovnaya Oxana | Chief Scientific Officer | M | Stock option (right to buy) | 45326 | $0.00 | 53,100.0000 | 0 | 46.05% | 0.00% |
| Jan. 4, 2023 | Beskrovnaya Oxana | Chief Scientific Officer | M | Stock option (right to buy) | 22674 | $0.00 | 30,426.0000 | 0 | 42.70% | 0.00% |
| Jan. 3, 2024 | McNeill Jonathan | Chief Business Officer | S | Common Stock | 10300 | $19.03 | 143,618.0000 | 0 | 6.69% | 0.00% |
| Jan. 3, 2024 | McNeill Jonathan | Chief Business Officer | S | Common Stock | 7691 | $18.34 | 153,918.0000 | 0 | 4.76% | 0.00% |
| Jan. 3, 2024 | McNeill Jonathan | Chief Business Officer | M | Common Stock | 17991 | $0.73 | 161,609.0000 | 0 | 12.53% | 0.00% |
| Jan. 2, 2024 | McNeill Jonathan | Chief Business Officer | S | Common Stock | 11900 | $13.10 | 143,618.0000 | 0 | 7.65% | 0.00% |
| Jan. 4, 2024 | McNeill Jonathan | Chief Business Officer | M | Stock option (right to buy) | 2009 | $0.00 | 48,528.0000 | 0 | 3.98% | 0.00% |
| Jan. 3, 2024 | Scalzo Richard William | SVP, Head of Finance & Admin. | M | Common Stock | 13000 | $1.03 | 137,228.0000 | 0 | 10.46% | 0.00% |
| Jan. 3, 2024 | Scalzo Richard William | SVP, Head of Finance & Admin. | S | Common Stock | 13000 | $18.81 | 124,228.0000 | 0 | 9.47% | 0.00% |
| Jan. 3, 2024 | McNeill Jonathan | Chief Business Officer | M | Stock option (right to buy) | 17991 | $0.00 | 50,537.0000 | 0 | 26.25% | 0.00% |
| Jan. 3, 2024 | Scalzo Richard William | SVP, Head of Finance & Admin. | M | Stock option (right to buy) | 13000 | $0.00 | 25,740.0000 | 0 | 33.56% | 0.00% |
| Jan. 4, 2024 | McNeill Jonathan | Chief Business Officer | S | Common Stock | 2009 | $18.04 | 143,618.0000 | 0 | 1.38% | 0.00% |
| Jan. 4, 2024 | McNeill Jonathan | Chief Business Officer | M | Common Stock | 2009 | $0.73 | 145,627.0000 | 0 | 1.40% | 0.00% |
| Jan. 3, 2024 | Beskrovnaya Oxana | Chief Scientific Officer | S | Common Stock | 15382 | $18.34 | 206,529.0000 | 0 | 6.93% | 0.00% |
| Jan. 3, 2024 | Brumm Joshua T | CEO & President | M | Common Stock | 51183 | $1.03 | 636,154.0000 | 0 | 8.75% | 0.00% |
| Jan. 3, 2024 | Brumm Joshua T | CEO & President | S | Common Stock | 15382 | $18.34 | 620,772.0000 | 0 | 2.42% | 0.00% |
| Jan. 3, 2024 | Brumm Joshua T | CEO & President | S | Common Stock | 19775 | $19.03 | 600,997.0000 | 0 | 3.19% | 0.00% |
| Jan. 3, 2024 | Brumm Joshua T | CEO & President | S | Common Stock | 16026 | $20.50 | 584,971.0000 | 0 | 2.67% | 0.00% |
| Jan. 4, 2024 | Brumm Joshua T | CEO & President | M | Common Stock | 18536 | $1.03 | 603,507.0000 | 0 | 3.17% | 0.00% |
| Jan. 4, 2024 | Brumm Joshua T | CEO & President | M | Common Stock | 200000 | $5.54 | 803,507.0000 | 0 | 33.14% | 0.00% |
| Jan. 4, 2024 | Brumm Joshua T | CEO & President | S | Common Stock | 180235 | $18.40 | 623,272.0000 | 0 | 22.43% | 0.00% |
| Jan. 4, 2024 | Brumm Joshua T | CEO & President | S | Common Stock | 38301 | $19.05 | 584,971.0000 | 0 | 6.15% | 0.00% |
| Jan. 3, 2024 | Brumm Joshua T | CEO & President | M | Stock option (right to buy) | 51183 | $0.00 | 18,536.0000 | 0 | 73.41% | 0.00% |
| Jan. 4, 2024 | Brumm Joshua T | CEO & President | M | Stock option (right to buy) | 18536 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 4, 2024 | Brumm Joshua T | CEO & President | M | Stock option (right to buy) | 200000 | $0.00 | 107,863.0000 | 0 | 64.96% | 0.00% |
| Dec. 14, 2023 | Scalzo Richard William | See Remarks | S | Common Stock | 2376 | $12.02 | 124,228.0000 | 0 | 1.88% | 0.00% |
| Dec. 11, 2023 | Farwell Wildon | Chief Medical Officer | S | Common Stock | 1688 | $10.72 | 170,074.0000 | 0 | 0.98% | 0.00% |
| Dec. 11, 2023 | Scalzo Richard William | See Remarks | S | Common Stock | 1380 | $10.72 | 126,604.0000 | 0 | 1.08% | 0.00% |
| Dec. 11, 2023 | McNeill Jonathan | Chief Business Officer | S | Common Stock | 1245 | $10.72 | 155,518.0000 | 0 | 0.79% | 0.00% |
| Dec. 11, 2023 | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 1616 | $10.72 | 187,882.0000 | 0 | 0.85% | 0.00% |
| Dec. 12, 2023 | Farwell Wildon | Chief Medical Officer | S | Common Stock | 978 | $10.55 | 169,096.0000 | 0 | 0.58% | 0.00% |
| Dec. 11, 2023 | Brumm Joshua T | See Remarks | S | Common Stock | 7585 | $10.72 | 584,971.0000 | 0 | 1.28% | 0.00% |
| Dec. 11, 2023 | Beskrovnaya Oxana | Chief Scientific Officer | S | Common Stock | 1467 | $10.72 | 176,585.0000 | 0 | 0.82% | 0.00% |
| Dec. 6, 2023 | Scalzo Richard William | See Remarks | S | Common Stock | 1872 | $12.01 | 127,984.0000 | 0 | 1.44% | 0.00% |
| Dec. 4, 2023 | Scalzo Richard William | See Remarks | S | Common Stock | 681 | $12.01 | 129,856.0000 | 0 | 0.52% | 0.00% |
| Nov. 15, 2023 | Scalzo Richard William | See Remarks | A | Common Stock | 89742 | $0.00 | 130,537.0000 | 0 | 219.98% | 0.00% |
| Nov. 15, 2023 | Scalzo Richard William | See Remarks | A | Stock Option (right to buy) | 34946 | $0.00 | 34,946.0000 | 0 | 9999.99% | 0.00% |
| Nov. 15, 2023 | McNeill Jonathan | Chief Business Officer | A | Common Stock | 96158 | $0.00 | 156,763.0000 | 0 | 158.66% | 0.00% |
| Nov. 15, 2023 | McNeill Jonathan | Chief Business Officer | A | Stock Option (right to buy) | 37445 | $0.00 | 37,445.0000 | 0 | 9999.99% | 0.00% |
| Nov. 15, 2023 | HIGH SUSANNA GATTI | Chief Operating Officer | A | Common Stock | 94893 | $0.00 | 189,498.0000 | 0 | 100.30% | 0.00% |
| Nov. 15, 2023 | HIGH SUSANNA GATTI | Chief Operating Officer | A | Stock Option (right to buy) | 36952 | $0.00 | 36,952.0000 | 0 | 9999.99% | 0.00% |
| Nov. 15, 2023 | Farwell Wildon | Chief Medical Officer | A | Common Stock | 82512 | $0.00 | 171,762.0000 | 0 | 92.45% | 0.00% |
| Nov. 15, 2023 | Farwell Wildon | Chief Medical Officer | A | Stock Option (right to buy) | 32131 | $0.00 | 32,131.0000 | 0 | 9999.99% | 0.00% |
| Nov. 15, 2023 | Brumm Joshua T | See Remarks | A | Common Stock | 358877 | $0.00 | 592,556.0000 | 0 | 153.58% | 0.00% |
| Nov. 15, 2023 | Brumm Joshua T | See Remarks | A | Stock Option (right to buy) | 139750 | $0.00 | 139,750.0000 | 0 | 9999.99% | 0.00% |
| Nov. 15, 2023 | Beskrovnaya Oxana | Chief Scientific Officer | A | Common Stock | 93718 | $0.00 | 178,052.0000 | 0 | 111.13% | 0.00% |
| Nov. 15, 2023 | Beskrovnaya Oxana | Chief Scientific Officer | A | Stock Option (right to buy) | 36495 | $0.00 | 36,495.0000 | 0 | 9999.99% | 0.00% |
| Nov. 2, 2023 | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 9939 | $7.40 | 94,605.0000 | 0 | 9.51% | 0.00% |
| Sept. 18, 2023 | Beskrovnaya Oxana | Chief Scientific Officer | S | Common Stock | 1436 | $9.41 | 84,334.0000 | 0 | 1.67% | 0.00% |
| Sept. 18, 2023 | Scalzo Richard William | See Remarks | S | Common Stock | 1290 | $9.41 | 40,795.0000 | 0 | 3.07% | 0.00% |
| Sept. 18, 2023 | McNeill Jonathan | Chief Business Officer | S | Common Stock | 1261 | $9.41 | 60,605.0000 | 0 | 2.04% | 0.00% |
| Sept. 18, 2023 | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 2672 | $9.41 | 104,544.0000 | 0 | 2.49% | 0.00% |
| Sept. 18, 2023 | Brumm Joshua T | See Remarks | S | Common Stock | 12032 | $9.41 | 233,679.0000 | 0 | 4.90% | 0.00% |
| Sept. 12, 2023 | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 1635 | $10.41 | 107,216.0000 | 0 | 1.50% | 0.00% |
| Sept. 12, 2023 | Beskrovnaya Oxana | Chief Scientific Officer | S | Common Stock | 1484 | $10.41 | 85,770.0000 | 0 | 1.70% | 0.00% |
| Sept. 12, 2023 | Farwell Wildon | Chief Medical Officer | S | Common Stock | 1707 | $10.41 | 89,250.0000 | 0 | 1.88% | 0.00% |
| Sept. 12, 2023 | Scalzo Richard William | See Remarks | S | Common Stock | 1397 | $10.41 | 42,085.0000 | 0 | 3.21% | 0.00% |
| Sept. 12, 2023 | McNeill Jonathan | Chief Business Officer | S | Common Stock | 1266 | $10.41 | 61,866.0000 | 0 | 2.01% | 0.00% |
| Sept. 12, 2023 | Brumm Joshua T | See Remarks | S | Common Stock | 7672 | $10.41 | 245,711.0000 | 0 | 3.03% | 0.00% |
| June 13, 2023 | Scalzo Richard William | See Remarks | M | Stock Option (right to buy) | 40000 | $0.00 | 38,740.0000 | 0 | 50.80% | 0.00% |
| June 15, 2023 | Scalzo Richard William | See Remarks | S | Common Stock | 10000 | $12.03 | 43,482.0000 | 0 | 18.70% | 0.00% |
| June 13, 2023 | Scalzo Richard William | See Remarks | S | Common Stock | 1390 | $12.43 | 53,482.0000 | 0 | 2.53% | 0.00% |
| June 13, 2023 | Scalzo Richard William | See Remarks | M | Common Stock | 40000 | $1.03 | 93,482.0000 | 0 | 74.79% | 0.00% |
| June 13, 2023 | Scalzo Richard William | See Remarks | S | Common Stock | 40000 | $12.89 | 53,482.0000 | 0 | 42.79% | 0.00% |
| June 13, 2023 | McNeill Jonathan | See Remarks | S | Common Stock | 1259 | $12.43 | 63,132.0000 | 0 | 1.96% | 0.00% |
| June 13, 2023 | Beskrovnaya Oxana | Chief Scientific Officer | S | Common Stock | 1475 | $12.43 | 87,254.0000 | 0 | 1.66% | 0.00% |
| June 13, 2023 | Farwell Wildon | Chief Medical Officer | S | Common Stock | 1698 | $12.43 | 90,957.0000 | 0 | 1.83% | 0.00% |
| June 13, 2023 | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 1625 | $12.43 | 108,851.0000 | 0 | 1.47% | 0.00% |
| June 12, 2023 | McNeill Jonathan | See Remarks | S | Common Stock | 1000 | $13.00 | 64,391.0000 | 0 | 1.53% | 0.00% |
| June 9, 2023 | Brumm Joshua T | See Remarks | S | Common Stock | 76582 | $13.34 | 269,771.0000 | 0 | 22.11% | 0.00% |
| June 8, 2023 | Brumm Joshua T | See Remarks | G | Common Stock | 20000 | $0.00 | 302,483.0000 | 0 | 6.20% | 0.00% |
| June 8, 2023 | Brumm Joshua T | See Remarks | G | Common Stock | 1800 | $0.00 | 300,683.0000 | 0 | 0.60% | 0.00% |
| June 8, 2023 | Brumm Joshua T | See Remarks | M | Common Stock | 30088 | $1.03 | 330,771.0000 | 0 | 10.01% | 0.00% |
| June 8, 2023 | Brumm Joshua T | See Remarks | S | Common Stock | 46811 | $13.15 | 283,960.0000 | 0 | 14.15% | 0.00% |
| June 8, 2023 | Brumm Joshua T | See Remarks | S | Common Stock | 14189 | $13.47 | 269,771.0000 | 0 | 5.00% | 0.00% |
| June 9, 2023 | Brumm Joshua T | See Remarks | M | Common Stock | 76582 | $1.03 | 346,353.0000 | 0 | 28.39% | 0.00% |
| June 12, 2023 | Brumm Joshua T | See Remarks | M | Stock Option (right to buy) | 171360 | $0.00 | 69,719.0000 | 0 | 71.08% | 0.00% |
| June 9, 2023 | Brumm Joshua T | See Remarks | M | Stock Option (right to buy) | 76582 | $0.00 | 241,079.0000 | 0 | 24.11% | 0.00% |
| June 8, 2023 | Brumm Joshua T | See Remarks | M | Stock Option (right to buy) | 30088 | $0.00 | 317,661.0000 | 0 | 8.65% | 0.00% |
| June 12, 2023 | Brumm Joshua T | See Remarks | S | Common Stock | 187748 | $12.61 | 253,383.0000 | 0 | 42.56% | 0.00% |
| June 12, 2023 | Brumm Joshua T | See Remarks | M | Common Stock | 171360 | $1.03 | 441,131.0000 | 0 | 63.52% | 0.00% |
| May 24, 2023 | HURWITZ EDWARD | Director | A | Stock Option (right to buy) | 24900 | $0.00 | 24,900.0000 | 0 | 9999.99% | 0.00% |
| May 24, 2023 | Incerti Carlo | Director | A | Stock Option (right to buy) | 24900 | $0.00 | 24,900.0000 | 0 | 9999.99% | 0.00% |
| May 24, 2023 | Kersten Dirk | Director | A | Stock Option (right to buy) | 24900 | $0.00 | 24,900.0000 | 0 | 9999.99% | 0.00% |
| May 24, 2023 | Lubner David Charles | Director | A | Stock Option (right to buy) | 24900 | $0.00 | 24,900.0000 | 0 | 9999.99% | 0.00% |
| May 24, 2023 | Rhodes Jason P | Director | A | Stock Option (right to buy) | 24900 | $0.00 | 24,900.0000 | 0 | 9999.99% | 0.00% |
| May 24, 2023 | Stehman-Breen Catherine | Director | A | Stock Option (right to buy) | 24900 | $0.00 | 24,900.0000 | 0 | 9999.99% | 0.00% |
| March 14, 2023 | Beskrovnaya Oxana | Chief Scientific Officer | S | Common Stock | 1416 | $13.33 | 88,729.0000 | 0 | 1.57% | 0.00% |
| March 14, 2023 | Farwell Wildon | Chief Medical Officer | S | Common Stock | 7441 | $13.33 | 92,655.0000 | 0 | 7.43% | 0.00% |
| March 14, 2023 | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 1559 | $13.33 | 110,476.0000 | 0 | 1.39% | 0.00% |
| March 14, 2023 | McNeill Jonathan | See Remarks | S | Common Stock | 1209 | $13.33 | 65,391.0000 | 0 | 1.82% | 0.00% |
| March 13, 2023 | McNeill Jonathan | See Remarks | S | Common Stock | 1000 | $13.00 | 66,600.0000 | 0 | 1.48% | 0.00% |
| March 14, 2023 | Scalzo Richard William | See Remarks | S | Common Stock | 1311 | $13.33 | 54,872.0000 | 0 | 2.33% | 0.00% |
| March 14, 2023 | Brumm Joshua T | See Remarks | S | Common Stock | 7318 | $13.33 | 322,483.0000 | 0 | 2.22% | 0.00% |
| Jan. 18, 2023 | McNeill Jonathan | See Remarks | M | Stock Option (right to buy) | 10000 | $0.00 | 68,528.0000 | 0 | 12.73% | 0.00% |
| Jan. 18, 2023 | McNeill Jonathan | See Remarks | S | Common Stock | 10000 | $14.03 | 67,600.0000 | 0 | 12.89% | 0.00% |
| Jan. 18, 2023 | McNeill Jonathan | See Remarks | M | Common Stock | 10000 | $0.73 | 77,600.0000 | 0 | 14.79% | 0.00% |
| Jan. 9, 2023 | McNeill Jonathan | See Remarks | S | Common Stock | 30150 | $11.57 | 67,600.0000 | 0 | 30.84% | 0.00% |